Results 151 to 160 of about 655,195 (289)

Fowl Cholera: Immunologic and Serologic Response in Turkeys to Live Pasteurella multocida Vaccine Administered in the Drinking Water

, 1975
K. L. Heddleston, P. A. Rebers, G. E. Wessman   +2 more
openalex   +1 more source

Strategic evaluations and techno-economic networks. Vaccine innovation in the Cuban biotech sector: for public health – or for profits? [PDF]

In this paper the Cuban biotech sector with its highly integrated vaccine industry is analyzed in the perspective of the techno-economic network model of Michel Callon. The paper discusses the strategic evaluations that have been performed in the sector.
Jens Plahte
core  

Determination of immune response against alum-precipitated fowl cholera vaccine in the quail, <i>Coturnix japonica</i>

, 1970
MT Iqbal, Md. Hakimul Haque, Subir Sarker, Md. Aminul Islam, KA Choudhury   +4 more
openalex   +2 more sources

A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery [PDF]

, 1999
François Cano, Sissela Liljeqvist, Thien Ngoc Nguyen, Patrik Samuelson, Jean‐Yves Bonnefoy, Stefan StÃ¥hl, Alain Robert   +6 more
openalex   +1 more source

Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions

Health Science Reports
Background and Aim Cholera is a life‐threatening infectious disease that is still one of the most common acute watery diarrheal diseases in the world today.
Abdulrahman K. Ahmed, Victor Coll Sijercic, Mahad S. Akhtar, Ahmed Elbayomy, Mohamed A. Marouf, Mahlet S. Zeleke, Reem Sayad, Abdelrahman Abdelshafi, Nicholas J. Laird, Mohamed A. El‐Mokhtar, Gregory R. Ruthig, Helal F. Hetta   +11 more
doaj   +1 more source

Evaluating And Testing Of A Potential Dna Vaccine Against Vibrio Cholerae [PDF]

, 2003
Although it has been more than 100 years since the first attempt to produce a cholera vaccine was made, an effective cholera vaccine has yet to be developed.
Moh’d Hamadneh, Lama Abdel Qader
core  

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

, 1989
S Migasena, P Pitisuttitham, B Prayurahong, Pravan Suntharasamai, Wichai Supanaranond, Varunee Desakorn, U Vongsthongsri, Ben D. Tall, J. Ketley, G Losonsky   +9 more
openalex   +1 more source

Albendazole Treatment of Children with Ascariasis Enhances the Vibriocidal Antibody Response to the Live Attenuated Oral Cholera Vaccine CVD 103‐HgR [PDF]

, 2000
Philip J. Cooper, Martha Chico, Genevieve A. Losonsky, Carlos Sandoval, Ivan Espinel, Rajeshwari Sridhara, M. Rodríguez Aguilar, Angel Guevara, Ronald H. Guderian, Myron M. Levine, George E. Griffin, Thomas B. Nutman   +11 more
openalex   +1 more source

Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan.

Lancet. Infectious Diseases (Print), 2017
L. A. Parker, J. Rumunu, Christine Jamet, Yona Kenyi, R. Lino, J. Wamala, A. Mpairwe, I. Ciglenecki, F. Luquero, A. Azman, J. Cabrol   +10 more
semanticscholar   +1 more source

Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine

, 1993
Ursula Wiedermann, L. Å. HANSON, Jan Holmgren, Helena Kahu, U. Dahlgren   +4 more
openalex   +1 more source